LDL-cholesterol, HDL-cholesterol or triglycerides - Which is the culprit?

Diabetes Research and Clinical Practice

Volumn 61, Issue SUPPL. 1, 2003, Pages

  Taskinen, Marja Riitta ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Dyslipidaemia; HDL cholesterol; LDL cholesterol; Statins; Triglycerides

Indexed keywords

CIPROFIBRATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATIN; TRIACYLGLYCEROL;

CARDIOVASCULAR RISK; CONFERENCE PAPER; DIET RESTRICTION; DRUG EFFECT; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; SEX RATIO;

EID: 0041668083     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(03)00126-8     Document Type: Conference Paper

References (24)

1. Haffner S.M., Lehto S., Ronemaa T., Pyörälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New Engl. J. Med. 339:1998;229-234.
2. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J. Am. Med. Assoc. 285:2001;2486-2497.
3. Turner R.C., Millns H., Neil H.A.W., et al. Risk factors for coronary artery disease in non-insulin-dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). Br. Med. J. 316:1998;823-828.
4. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24:2001;683-689.
5. Management of dyslipidemia in adults with diabetes. Diabetes Care. 25:(Suppl. 1):2002;S74-S77.
6. Harris M.I. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care. 23:2000;754-758.
7. Heine R.J., Dekker J.M. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia. 45:2002;461-475.
8. Evans M., Anderson R.A., Graham J., et al. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation. 101:2000;1773-1779.
9. Gray R.S., Robbins D.C., Wang W., et al. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. Arterioscler. Thromb. Vasc. Biol. 17:1997;2713-2720.
10. Austin M.A., Breslow J.L., Hennekens C.H., Buring J.E., Willett W.C., Krauss R.M. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J. Am. Med. Assoc. 260:1988;1917-1921.
11. Gardner C.D., Fortmann S.P., Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. J. Am. Med. Assoc. 276:1996;875-881.
12. Tan K.C.B., Ai V.H.G., Chow W.S., Chau M.T., Leong L., Lam K.S.L. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilatation in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 84:1999;3212-3216.
13. Mäkimattila S., Liu M.-L., Vakkilainen J., et al. Impaired endothelium-dependent vasodilatation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care. 22:1999;973-981.
14. Vakkilainen J., Mäkimattila S., Seppälä-Lindroos A., et al. Endothelial dysfunction in men with small LDL particles. Circulation. 102:2000;716-721.
15. Skoglund-Andersson C., Tang R., Bond M.G., de Faire U., Hamsten A., Karpe F. LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men. Arterioscler. Thromb. Vasc. Biol. 19:1999;2422-2430.
16. Laakso M., Lehto S., Penttila I., Pyörälä K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation. 88:1993;1421-1430.
17. Syvänne M., Taskinen M.-R. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet. 350:(Suppl. I):1997;20-23.
18. Lamarche B., Uffelman K.D., Carpentier A., et al. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J. Clin. Invest. 103:1999;1191-1199.
19. Toikka J.O., Ahotupa M., Viikari J.S. Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis. 147:1999;133-138.
20. Spieker L.E., Sudano I., Hurlimann D., et al. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation. 105:2002;1399-1402.
21. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 360:2002;7-22.
22. Syvanne M., Vuorinen-Markkola H., Hilden H., Taskinen M.R. Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus. Arterioscler. Thromb. 13:1993;286-295.
23. Syvanne M., Hilden H., Taskinen M.R. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. J. Lipid Res. 35:1994;15-26.
24. Alagona C., Soro A., Ylitalo K., Salonen R., Salonen J.T., Taskinen M.R. A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families. Atherosclerosis. 165:2002;309-316.